These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36841305)

  • 1. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis.
    Kim D; Dennis BB; Cholankeril G; Ahmed A
    J Affect Disord; 2023 May; 329():184-191. PubMed ID: 36841305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of depression score with metabolic dysfunction-associated fatty liver disease and liver fibrosis.
    Cai H; Zhang R; Zhao C; Wang Y; Tu X; Duan W
    J Affect Disord; 2023 Aug; 334():332-336. PubMed ID: 37142003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease.
    Xiao P; Liang P; Gao P; Wu J
    Front Endocrinol (Lausanne); 2022; 13():1057261. PubMed ID: 36531457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study.
    Yu G; Liu L; Qin T; Luo Y; Song C; Chen X; Duan H; Jiang Y; Zeng H; Wan H; Shen J
    Biol Trace Elem Res; 2024 Jan; 202(1):87-98. PubMed ID: 37079265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
    Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents.
    Ciardullo S; Carbone M; Invernizzi P; Perseghin G
    Hepatol Commun; 2022 Aug; 6(8):2070-2078. PubMed ID: 35470984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population.
    Yang S; Cheng J; Zhang R; Sun H; Zhang H; Lyu S; Duan W
    Hepatol Res; 2022 Feb; 52(2):176-186. PubMed ID: 34751487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease.
    Chun HS; Kim MN; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1168-1178. PubMed ID: 34337887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
    Seo JY; Cho EJ; Kim MJ; Kwak MS; Yang JI; Chung SJ; Yim JY; Yoon JW; Chung GE
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2953-2960. PubMed ID: 36222309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
    Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations.
    Feng Z; Zhao F; Wang Z; Tang X; Xie Y; Qiu L
    BMC Gastroenterol; 2024 Mar; 24(1):111. PubMed ID: 38491346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han E; Lee YH; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Kim SU
    Gut Liver; 2022 Sep; 16(5):786-797. PubMed ID: 35321955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population.
    Ciardullo S; Perseghin G
    Liver Int; 2021 Jun; 41(6):1290-1293. PubMed ID: 33590934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
    Hu Q; Chen Y; Bao T; Huang Y
    Ren Fail; 2022 Dec; 44(1):1996-2005. PubMed ID: 36374233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study.
    Lee GB; Huh Y; Lee SH; Han B; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Nam GE
    World J Gastroenterol; 2023 Dec; 29(45):5962-5973. PubMed ID: 38131000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
    Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
    Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between self-reported snoring and metabolic-associated fatty liver disease: A cross-sectional analysis of the NHANES 2017-2018.
    Wang Y; Shen R; Ge J
    Sleep Med; 2023 Jan; 101():414-420. PubMed ID: 36516525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.